Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study

By sjmartinez • April 11, 2023

Chen HY, Dina C, Small AM, Shaffer CM, Levinson RT, Helgadóttir A, Capoulade R, Munter HM, Martinsson A, Cairns BJ, Trudsø LC, Hoekstra M, Burr HA, Marsh TW, Damrauer SM, Dufresne L, Le Scouarnec S, Messika-Zeitoun D, Ranatunga DK, Whitmer RA, Bonnefond A, Sveinbjornsson G, Daníelsen R, Arnar DO, Thorgeirsson G, Thorsteinsdottir U, Gudbjartsson DF, Hólm H, Ghouse J, Olesen MS, Christensen AH, Mikkelsen S, Jacobsen RL, Dowsett J, Pedersen OBV, Erikstrup C, Ostrowski SR; Regeneron Genetics Center; O'Donnell CJ, Budoff MJ, Gudnason V, Post WS, Rotter JI, Lathrop M, Bundgaard H, Johansson B, Ljungberg J, Näslund U, Le Tourneau T, Smith JG, Wells QS, Söderberg S, Stefánsson K, Schott JJ, Rader DJ, Clarke R, Engert JC, Thanassoulis G. Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study. Eur Heart J. 2023 Apr 11:ehad142. doi: 10.1093/eurheartj/ehad142. Epub ahead of print. PMID: 37038246.

Tags: Aortic stenosis, Cardiology/Epi, gene expression, genetic risk score, Genome-wide association study, Mendelian randomization, Phenome-wide association study, Publications

Serine protease inhibitor, SerpinA3n regulates cardiac remodeling after myocardial infarction

Sun Q, Chen W, Wu R, Tao B, Wang P, Sun B, Alvarez JF, Ma F, Galindo DC, Maroney SP, Saviola AJ, Hansen KC, Li[...]

Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021

Sayed A, Abramov D, Fonarow GC, Mamas MA, Kobo O, Butler J, Fudim M. Reversals in the Decline of Heart Failure Mortality in the US,[...]

Early-Onset Hypertension and Sex-Specific Residual Risk for Cardiovascular Disease in Type 2 Diabetes

Ji H, Ebinger JE, Kwan AC, Reue K, Sullivan JC, Shyy J, Cheng S. Early-Onset Hypertension and Sex-Specific Residual Risk for Cardiovascular Disease in Type[...]